# Gene Therapy for Chronic Granulomatous Disease

> **NCT00564759** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 2 (actual)

## Conditions studied

- Granulomatous Disease, Chronic

## Interventions

- **DRUG:** retroviral SF71-gp91phox transduced CD34+ cells

## Key facts

- **NCT ID:** NCT00564759
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2007-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564759, "Gene Therapy for Chronic Granulomatous Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00564759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*